However, the use of genetically modified yeasts has received
opposition in the European Union, Australia, and
South Africa. BioSpringer, a division of Lesaffre Yeast
Corporation, has commercialized ML01 in the United
States and the Republic of Moldova (Husnik et al. 2007).